VISIT OUR OFFICIAL SITE: https://www.edhacare.com/treatments/cancer/car-t-cell-therapy 

CAR T-cell therapy can be combined with t cell products that are separately infused together. CAR T cells are generated from monoclonal antibodies.Thus, CAR architectures give T cells with the tremendous variety and high affinity/specificity of mAbs against tumour antigens, in addition to their cytolytic effectiveness.Chimeric Antigen Receptor (CAR) T-cell therapy is recognise and kill antigen expressing cancer cells.This personalized treatment has shown remarkable success in treating certain types of blood cancers, offering new hope for patients who have not responded to traditional treatments.